Fig. 5From: Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regressionMeta-regression analysis between the differences in achieved HbA1c at the end of cardiovascular outcome trials (CVOTs) and the corresponding hazard ratio (HR) for hospitalization for heart failure (HF) in patients with type 2 diabetes participating in 18 CVOTsBack to article page